I agree that this site is using cookies. You can find further informations here.
X
Maclachlan, Kylee
94  results:
Search for persons X
?
1

Patterns of CRS with teclistamab in relapsed/refractory mul..:

Hamadeh, Issam S. ; Shekarkhand, Tala ; Rueda, Colin...
Blood Advances.  8 (2024)  12 - p. 3038-3044 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Prognostic impact of corticosteroid and tocilizumab use fol..:

Costa, Bruno Almeida ; Flynn, Jessica ; Nishimura, Noriko...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Prevalence and impact of diabetes on survival of patients w..:

Shah, Urvi A. ; Moshier, Erin ; Derkach, Andriy...
Blood Advances.  8 (2024)  1 - p. 236-247 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Comparison of infectious complications with BCMA-directed t..:

Nath, Karthik ; Shekarkhand, Tala ; Nemirovsky, David...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
5

P-483 A whole foods plant-based weight loss intervention im..:

Shah, Urvi ; Derkach, Andriy ; Castro, Francesca...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S305-S306 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P-039 Vitamin D deficiency and clinical outcomes with chime..:

Nishimura, Noriko ; Flynn, Jessica ; Costa, Bruno...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S55-S56 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-486 Clinical significance of baseline body mass index and..:

Thirugnanasambandam, Ram Prakash ; Firestone, Ross ; Derkach, Andriy...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S307-S308 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Genomic and immune signatures predict clinical outcome in n..:

Maura, Francesco ; Boyle, Eileen M. ; Coffey, David...
Nature Cancer.  4 (2023)  12 - p. 1660-1674 , 2023
Link: https://doi.org/10.1038/..
 
?
9

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED R..:

Firestone, Ross ; Shekarkhand, Tala ; Patel, Dhwani...
HemaSphere.  7 (2023)  S3 - p. e81198bb , 2023
Link: https://doi.org/10.1097/..
 
?
10

OA-19 Comprehensive genomic characterization of response an..:

Maclachlan, Kylee ; Tan, Carlyn Rose ; Shekarkhand, Tala...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S12 , 2023
Link: https://doi.org/10.1016/..
 
?
11

P-357 Individualized risk in newly diagnosed multiple myelo..:

Maura, Francesco ; Rajanna, Arjun ; Ziccheddu, Bachisio...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S236 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P-484 Successful incorporation of ePRO using PROMIS-29 into..:

Shah, Gunjan ; Lobaugh, Stephanie ; Devlin, Sean...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S306 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P-038 Impact of absolute lymphocyte count at pre-apheresis ..:

Nishimura, Noriko ; Flynn, Jessica ; Costa, Bruno...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S55 , 2023
Link: https://doi.org/10.1016/..
 
?
14

P-095 Evolving M-spike and risk of progression in smolderin..:

Hultcrantz, Malin ; Nemirovsky, David ; Akhlaghi, Theresia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S87 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P-354 Whole genome sequencing reveals significant genetic a..:

Maclachlan, Kylee ; Blaney, Patrick ; Gagler, Dylan...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S234-S235 , 2023
Link: https://doi.org/10.1016/..
 
1-15